Cannova is developing an alternative method for cannabis consumption in the form of a sublingual strip. The sublingual strips are infused with cannabis molecules that are produced using a patent-protected process involving the combination of various formulations with water-soluble cannabinoids and natural active ingredients. The sublingual strip allows producers to more effectively control dosage quantities and significantly increases the effect of the cannabis, allowing it to be used for a variety of purposes including pain management, concentration, as an antidepressant, and to support better sleep.
Additionally, Cannova is developing the NovaJet Pro (“NovaJet”), an innovative, counter-top machine that enables clients to create customized film strips at the convenience of their homes, in real time. With the NovaJet, clients will be able to receive accurate and tailored sublingual strips with specific measured quantities of cannabinoids and other natural substances, customized to their unique demand
Cumulative Funding Raised Over Time ($)
Employees Over Time
Cannova Medical Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 25, 2019
www.globenewswire.com
Nabis Holdings Closes Acquisition of 49% of Cannova Medical, A Creator of Innovative Solutions for Cannabis Consumption